News

North America Dermatology vice president Jean-Christophe May said, "Stiefel is dedicated to meeting the needs of patients and dermatologists and we believe Fabior Foam will be an important

The milestone follows the development and delivery of a prototype formulation of an Ironwood candidate meeting pre-specified attributes under the agreement signed to license Acuform technology signed in

The generic version of Pfizer’s Lipitor is indicated to prevent cardiovascular disease and hypercholesterolemia. Mylan CEO Heather Bresch said, "Mylan’s launch of Atorvastatin Calcium Tablets will help to

The Quad is a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate. Gilead HIV therapeutics and development operations senior vice president Andrew Cheng said,

The system is built on a platform which consists of intuitive controls that require minimal training to operate. Viztek sales vice president Steve Deaton said, "It’s the first

Adcetris, which is an antibody-drug conjugate (ADC) directed to CD30, has not been approved for use in CTCL. The trial enrolled 17 CTCL patients, which include 16 mycosis

The randomized, placebo-controlled single-dose escalation Phase I study enrolled patients with ATTR into seven sequential cohorts of increasing doses ranging from 0.01 to 1.0mg/kg. Patients administered with ALN-TTR01

The two outlets are located at 9140 Guilbeau Road and 22202 Bulverde Road, San Antonio. The clinics will operate seven days a week including weekday evenings and no

Meeting the study’s primary and secondary efficacy endpoints, Prolensa produced statistically greater clearing of subjects’ ocular inflammation by Day 15 and a greater proportion of subjects that were